2-[(6-{[4-(butylamino)-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}pyridazin-3-yl)oxy]acetamide
Chemical Structure Depiction of
2-[(6-{[4-(butylamino)-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}pyridazin-3-yl)oxy]acetamide
2-[(6-{[4-(butylamino)-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}pyridazin-3-yl)oxy]acetamide
Compound characteristics
| Compound ID: | D163-0023 |
| Compound Name: | 2-[(6-{[4-(butylamino)-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}pyridazin-3-yl)oxy]acetamide |
| Molecular Weight: | 404.43 |
| Molecular Formula: | C17 H24 N8 O4 |
| Smiles: | CCCCNc1nc(nc(n1)Oc1ccc(nn1)OCC(N)=O)N1CCOCC1 |
| Stereo: | ACHIRAL |
| logP: | 1.6523 |
| logD: | 1.6523 |
| logSw: | -2.0836 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 3 |
| Polar surface area: | 120.854 |
| InChI Key: | PTRQUCPEQJETEP-UHFFFAOYSA-N |